Search research articles
Contact Us
Filters
Showing results (31-40 of 197) with videos related to
Page
of 20
Sort By:
Expert Review of Clinical Immunology
|
February 11, 2015
Tofacitinib for the treatment of moderate-to-severe psoriasis
Andrea Chiricozzi, Sara Faleri, Rosita Saraceno, et al.
Expert Opinion on Biological Therapy
|
December 6, 2013
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers
Rosita Saraceno, Francesca Specchio, Andrea Chiricozzi, et al.
Autoimmunity Reviews
|
April 3, 2020
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay
Paola Conigliaro, Arianna D'Antonio, Sara Pinto, et al.
The Journal of International Medical Research
|
September 30, 2016
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor
Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, et al.
Case Reports in Immunology
|
March 27, 2024
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review
Mario Ferraioli, Luigi Fiannacca, Elisabetta Greco, et al.
Acta Dermato-Venereologica
|
December 24, 2003
High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis
Elena Campione, Georgiana Clare Marulli, Anna Maria Carrozzo, et al.
Journal of Dermatological Case Reports
|
October 30, 2015
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature
Maria Sole Chimenti, Marina Talamonti, Lucia Novelli, et al.
Dermatology (Basel, Switzerland)
|
October 31, 2008
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
Antonio Costanzo, Marina Talamonti, Giulia Spallone, et al.
Expert Opinion on Biological Therapy
|
August 13, 2013
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
Rosita Saraceno, Mauro Bavetta, Arianna Zangrilli, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Efficacy and safety of infliximab in psoriatic patients over the age of 65
Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 197) with videos related to
Sort By:
Page
of 20
Expert Review of Clinical Immunology
|
February 11, 2015
Tofacitinib for the treatment of moderate-to-severe psoriasis
Andrea Chiricozzi, Sara Faleri, Rosita Saraceno, et al.
Expert Opinion on Biological Therapy
|
December 6, 2013
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers
Rosita Saraceno, Francesca Specchio, Andrea Chiricozzi, et al.
Autoimmunity Reviews
|
April 3, 2020
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay
Paola Conigliaro, Arianna D'Antonio, Sara Pinto, et al.
The Journal of International Medical Research
|
September 30, 2016
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor
Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, et al.
Case Reports in Immunology
|
March 27, 2024
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review
Mario Ferraioli, Luigi Fiannacca, Elisabetta Greco, et al.
Acta Dermato-Venereologica
|
December 24, 2003
High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis
Elena Campione, Georgiana Clare Marulli, Anna Maria Carrozzo, et al.
Journal of Dermatological Case Reports
|
October 30, 2015
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature
Maria Sole Chimenti, Marina Talamonti, Lucia Novelli, et al.
Dermatology (Basel, Switzerland)
|
October 31, 2008
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
Antonio Costanzo, Marina Talamonti, Giulia Spallone, et al.
Expert Opinion on Biological Therapy
|
August 13, 2013
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
Rosita Saraceno, Mauro Bavetta, Arianna Zangrilli, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Efficacy and safety of infliximab in psoriatic patients over the age of 65
Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, et al.
Page
of 20